TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis.
John A MackintoshMaria PietschViviana LutzkyDebra EneverSandra BancroftSimon H ApteMaxine TanStephanie T YerkovichJoanne L DickinsonHilda A PickettHiran SelvaduraiChristopher GraingeNicole S GohPeter HopkinsIan GlaspolePaul N ReynoldsJeremy WrobelAdam JaffeTamera J CorteDaniel C ChambersPublished in: BMJ open respiratory research (2021)
NCT04638517; Australian New Zealand Clinical Trials Registry (ACTRN12620001363976p).